Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 3 1

Status

Completed 6Recruiting 3Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 35Prostate Cancer Metastatic 3Neoplasm Metastasis 3Prostate CA 2Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2Triple Negative Breast Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Oligometastatic Prostate Cancer 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-resistant Prostate Cancer 1Intraprostatic Prostate Cancer 1Genital Diseases, Male 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 49Specimen Handling 29Magnetic Resonance Spectroscopy 25Biopsy 25Radiosurgery 17Gemcitabine 17Nivolumab 16Cyclophosphamide 14Cisplatin 14Paclitaxel 13Carboplatin 13Bevacizumab 13Leucovorin 11Irinotecan 11Fluorouracil 11Drug Therapy 11Taxes 10Radiotherapy 10Oxaliplatin 10Capecitabine 10trastuzumab deruxtecan 9fludarabine 9cemiplimab 8Doxorubicin 8Cetuximab 8abemaciclib 7Trastuzumab 7Pemetrexed 7Fulvestrant 7Docetaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Metastasis × Androgen Antagonists × Clear all
NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting
464 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT07426094 2026-03-23

PRO-BOOST-N

Affidea Nu-med Center of Oncological DIagnostics and Therapy

Phase 2/3 Recruiting
1,600 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT05352178 2024-07-03

SPARKLE

Universitaire Ziekenhuizen KU Leuven

Phase 3 Recruiting
873 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡